Beiersdorf Ag

Gesellschaft Fur Biotechnologische Forschung Mbh

Other

Wolfgang Meyer-Ingold

Wolfram Eichner

Albrecht Dorschner

Peter Himmelsbach

Hanns Pietsch

Holger Kartheus

Andreas B Kummer

Karl-Heinz Woeller

Heiko Mielke

Manfred Wirth

Volker Achterberg

Barbara Krug

Volker Hohmann

Thorsten Berg

Hansjorg Hauser

Ingrid Wesselkamp

Michael Schink

Carsten Hartkopf

Wilhem Dirks

Ernst-Joachim Henssge

Norbert Ettner

Christian Gaede

Wilhelm Dirks

Karl G Doppler

Andre Ljutow

Jan Jaenichen

Juergen Christian Quandt

Michael Bogdahn

Acrylate adhesive composition comprising N-methacryloyl-3,4-dihydroxyphenylalanine and/or N-acrylol-3,4-dihydroxyphenylalanine. The adhesive composition ensures an adhesion of substrates under moist conditions, in particular a biocompatible and waterproof adhesion to human skin.

Acrylate adhesive composition with water-resistant adhesive properties

A backing material for medical use with a pressure-sensitively adhesive coating on at least one side, having an ultimate tensile stress strength of at least 800 cN/cm and a bond strength to the reverse of the backing of not less than 10 cN/cm, the latex-free, cold seal composition applied to the backing material comprising one or more block copolymers having a styrene content of less than 65% by weight and having a tan &dgr; of less then 0.4 at a temperature of 25&deg; C. and a frequency of 100 rad/s.

Support material with a cohesive adhesive substance

The invention relates to novel wound coverings with which interfering factors of the wound healing process can be removed from the wound fluid of chronic wounds in a controlled manner and the normal healing process is promoted.

Wound coverings for removal of interfering factors from wound fluid

Multicistronic expression units allow the equimolar expression of the genes located in the corresponding cistrons. These expression units are particularly suitable for the recombinant production of proteins composed of two or more polypeptide subunits.

Multicistronic expression units and their use

The recombinant production of PDGF-AB in mammalian cells is disclosed by means of a bicistronic vector system in which an IRES sequence is located between the first and second cistrons and in which the B chain coding gene is located in the first cistron. The disclosed expression unit allows the equilmolar expression of the A and B polypeptide chains.

Process for producing a pharmaceutical preparation of PDGF-AB

Preparation of heterodimeric PDGF-AB using a bicistronic vector system

In a surgical composition comprising a liquid monomeric and powdered polymeric acrylate or methacrylate, a catalyst and an accelerator, the composition upon mixing of the liquid and powdered constituents passing through a plastic state to a solid state, the improvement which comprises including in the composition about 1 to 15% by weight of dimethyl sulfoxide. The product exhibits reduced cytotoxicity.

Surgical material

Growing community of inventors

Hamburg, Germany

Wolfgang Meyer-Ingold